The British Business Bank (BBB) has announced an £8 million investment into NRG Therapeutics Ltd., a pioneering neuroscience company developing novel therapies for severe neurodegenerative conditions, as part of a £50 million Series B funding round. The financing was led by SV Health Investors’ Dementia Discovery